Abstract: This disclosure relates to luciferin amides of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to detect fatty acid amide hydrolase activities in vitro, in live cells, or in vivo.
Abstract: A simple process for producing v-coelenterazine compounds has been desired. Described is a process for producing a v-coelenterazine compound represented by general formula (II) comprising (1) the step of reacting a compound of general formula (VIII) with a methyltriphenylphosphonium salt in the presence of a base to give a compound represented by general formula (IX), (2) the step of performing a ring-closing metathesis reaction on any one selected from the group consisting of the compound represented by general formula (IX) and a compound of general formula (X) which is the compound of general formula (IX) wherein the amino is protected with R5, and then deprotecting R4 and, if any, R5 to give a v-coelenteramine compound represented by general formula (XIV), and (3) the step of reacting the compound of general formula (XIV) with a compound represented by general formula (XV) to give the compound of general formula (II).
Type:
Grant
Filed:
March 6, 2012
Date of Patent:
July 8, 2014
Assignees:
JNC Corporation, National University Corporation Tokyo Medical and Dental University
Abstract: A bistable element (100) comprising: a multi-mode interference optical waveguide (1), has two ports on one edge face (1a) thereof, and has one port on the other edge face (1b) thereof; a first group of optical waveguides (2), and each of which is composed of two optical waveguides each having one edge face connected to each port arranged on the one edge face (1a) side of the multi-mode interference optical waveguide (1); and a second group of optical waveguides (3), and each of which is composed of one optical waveguide having one edge face connected to each port arranged on the other edge face (1b) side of the multi-mode interference optical waveguide (1). The multi-mode interference optical waveguide (1) has a saturable absorption region (22) where the absorption coefficient is reduced to cause the saturation of the amount of absorbed light when the intensity of incident light becomes high.
Type:
Grant
Filed:
July 17, 2012
Date of Patent:
July 8, 2014
Assignee:
Kyushu University, National University Corporation
Abstract: Heparin is synthesized from a polysaccharide comprised of a 1-4 glycosidically linked alternating polymer of uronic acid and glucosamine residues, wherein the uronic acid is selected from iduronic and glucuronic acid, wherein the glucosamine is partially N-sulfated; by a series of selective reactions catalyzed by recombinant enzymes.
Type:
Grant
Filed:
March 12, 2012
Date of Patent:
July 8, 2014
Assignees:
The University of North Carolina at Chapel Hill, Rensselaer Polytechnic Institute
Inventors:
Jian Liu, Robert J. Linhardt, Fikri Y. Avci, Ava M. Munoz, Jinghua Chen
Abstract: The present disclosure is directed to a method of producing nitric oxide comprising (i) providing a composition comprising a metal-organic framework, and (ii) exposing the composition to a nitric oxide-releasing compound. The disclosure also is directed to compositions, coatings, and medical devices comprising a metal-organic framework.
Type:
Grant
Filed:
December 28, 2010
Date of Patent:
July 8, 2014
Assignee:
Colorado State University Research Foundation
Inventors:
Melissa M. Reynolds, Benjamin P. Reynolds
Abstract: The invention relates to a technical field of graphic image processing, especially to a technology for simplifying a complex path. The invention provides a method and a device for simplifying a complex path, to accomplish simplification of any complex path into a simple path of a region described by the complex path. The method for simplifying a complex path comprises: parsing the complex path into a vector linked-list consisted of linked monotonic vectors; dividing each vector in the vector linked-list into vector segments according to intersection points of the vector with other vectors in the vector linked-list; and extracting from all vector segments the vector segments located on a boundary of a region defined by the complex path, and connecting the extracted vector segments according to their location to obtain a simple path.
Type:
Grant
Filed:
September 28, 2009
Date of Patent:
July 8, 2014
Assignees:
Peking University Founder Group Co., Ltd, Beijing Founder Electronics Co., Ltd
Abstract: On-chip test architecture and design-for-testability methods for pre-bond testing of TSVs are provided. In accordance with certain embodiments of the invention, a die level wrapper is provided including gated scan flops connected to one end of each TSV. The gated scan flops include a scan flop structure and a gated output. The gated output is controlled by a signal to cause the output of the gated scan flop to either be in a “floated state” or take the value stored in the flip-flop portion of the gated scan flop. The gated output of the gated scan flop can be used to enable resistance and capacitance measurements of pre-bonded TSVs.
Abstract: A solid state energy conversion device and method of making is disclosed for converting energy between electromagnetic and electrical energy. The solid state energy conversion device comprises a wide bandgap semiconductor material having a first doped region. A thermal energy beam is directed onto the first doped region of the wide bandgap semiconductor material in the presence of a doping gas for converting a portion of the first doped region into a second doped region in the wide bandgap semiconductor material. A first and a second Ohmic contact are applied to the first and the second doped regions of the wide bandgap semiconductor material. In one embodiment, the solid state energy conversion device operates as a light emitting device to produce electromagnetic radiation upon the application of electrical power to the first and second Ohmic contacts.
Abstract: Selective, non-peptide antagonists of the mu opioid receptor (MOR) and methods of their use are provided. The antagonists may be used, for example, to identify MOR agonists in competitive binding assays, and to treat conditions related to addiction in which MOR is involved, e.g. heroin, prescription drug and alcohol addiction.
Type:
Grant
Filed:
January 15, 2010
Date of Patent:
July 8, 2014
Assignee:
Virginia Commonwealth University
Inventors:
Yan Zhang, Dana E. Selley, William Dewey
Abstract: Disclosed are example methods and devices for detecting one or more targets. An example method includes placing a sample including a first target with in a microfluidic device and hybridizing a plurality of copies of the first target with a plurality of nanostructures. The example method includes applying an electric current to the plurality of nanostructures and using an electric field created by the electric current to move the plurality of nanostructures. In addition, the plurality of nanostructures are sorted and evaluated to determine at least one of a presence, an absence, or a quantity of the first target.
Abstract: The anthropomorphic force-reflective master arm is a light, anthropomorphic, back-drivable, six degree of freedom (DOF) master arm designed to control the motion of a remote slave device having arbitrary structure. Three of the link members are rotationally coupled to each other to form a handle, such that axes of rotation of each of the handle link members intersects at the user's hand position. The kinematics of the master arm is simplified to two independent sub-systems, which are the hand position and hand orientation.
Type:
Grant
Filed:
May 2, 2011
Date of Patent:
July 8, 2014
Assignees:
King Fahd University of Petroleum and Minerals, King Abdulazia City for Science and Technology
Abstract: Improved assays for detecting the presence of a specific cell-mediated immune response in an individual are provided, where a sample comprising T cells and other cells of the immune system, usually a blood sample or derivative thereof, is contacted with test antigen(s) of interest in the presence of a pattern recognition receptor (PRR) agonist. The sample is incubated for a period of time sufficient to activate effector T cells; and release of immune effector molecule(s) is then detected. In some embodiments, the PRR is an agonist of a toll-like receptor (TLR) expressed by mature antigen presenting cells, including without limitation agonists TLR3 and TLR7, such as LPS, poly I:C, imiquimod, etc.
Type:
Grant
Filed:
November 16, 2011
Date of Patent:
July 8, 2014
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Abstract: A method and device for aggregating algae in an aqueous solution is disclosed. The method can include providing an algae feed comprising a liquid and algae dispersed therein. The algae feed can be aggregated by applying a nanosecond pulsed electric field to the algae feed. The nanosecond pulsed electric field can include a plurality of electric pulses having a pulse duration ranging from 1 to 1,000 nanoseconds. The method can also include separating an aggregated algae stream from the algae feed and feeding the aggregated algae stream to a lipid extraction operation.
Type:
Grant
Filed:
June 25, 2010
Date of Patent:
July 8, 2014
Assignee:
Old Dominion University Research Foundation
Inventors:
Gary C. Schafran, Juergen F. Kolb, Aron Stubbins, Karl H. Schoenbach
Abstract: Modular hydraulic packer-and-port system and corresponding methods of operation. The system may be installed for temporary, semi-permanent, or permanent deployments. The system and method may provide for hydraulic isolation of target zones in a well while allowing pass-through tubes to the target zones for taking samples, inserting monitoring sensors, and the like.
Abstract: A sheathless flow cytometry system is disclosed wherein a fluid containing particles of interest is illuminated in the sensing region with a light source. Light resulting from the interaction of the particles with the illumination is received by a lens, and focused toward a field stop having an aperture comprising relatively large end portions and a relatively small center portion. Light deflectors are disposed over the relatively large end portions of the aperture. The system is arranged such that light from particles in focus in the sensing region is focused on the relatively small center portion of the aperture. Peripheral detectors receive light from the light deflectors, and a center light detector receives light passing through the center portion. The detector signals may be used to identify which of the detector signals correspond to particles in focus as they passed through the sensing region.
Abstract: A wound treatment system includes a sponge including a first surface adapted to confront a wound bed of a patient, a drape in contact with a second surface of the sponge, and a vacuum source for distributing a vacuum force through the sponge. The system also includes a wound separator having a sidewall defining an interior chamber, wherein at least a portion of an exterior of the sidewall confronts at least an interior portion of the sponge. An ostomy appliance is operatively connected to the wound separator to receive substances passing out of the wound separator.
Abstract: The present invention relates to methods of detecting novel mutations in a PKD1 and/or PKD2 gene that have been determined to be associated with autosomal dominant polycystic kidney disease (ADPKD) in order to detect or predict the occurrence of ADPKD in an individual.
Type:
Grant
Filed:
July 24, 2007
Date of Patent:
July 8, 2014
Assignees:
Athena Diagnostics, Inc., The Johns Hopkins University
Inventors:
Terry J. Watnick, Miguel Garcia-Gonzales, Gregory G. Germino, Jeffrey G. Jones
Abstract: Disclosed is a novel marine microorganism which can metabolize 3,6-anhydro-L-galactose and use of the same. The novel marine microorganism belongs to Vibrio sp. which utilizes 3,6-anhydro-L-galactose (3,6-L-AHG) as a single carbon source to convert 3,6-L-AHG to ribose and 3,6-anhydrogalactonic acid.
Type:
Grant
Filed:
July 25, 2012
Date of Patent:
July 8, 2014
Assignee:
Korea University Research and Business Foundation
Inventors:
Kyoung Heon Kim, In Geol Choi, Eun Ju Yun, Sae Young Lee
Abstract: The present invention relates to a transformant for inhibiting glycerol production through deletion of glycerol producing genes of Saccharomyces cerevisiae modified so as to use glycerol as a fermentation source, or enhancing bioethanol production through overexpression of TATA-binding proteins, SPT3 and SPT15, and a method for producing ethanol by using the transformant.
Type:
Grant
Filed:
April 15, 2011
Date of Patent:
July 8, 2014
Assignee:
Korea University Research and Business Foundation
Inventors:
Sung Ok Han, Kyung Ok Yu, Seung Wook Kim
Abstract: A process is disclosed for the biological treatment under anaerobic/anoxic conditions for the degradation of pollutants present in brine solution used in waste water management, in industrial waste brine solutions and in waste oil field brine solutions, especially waste brine solutions contaminated with perchlorate and nitrate. A culture capable of reducing perchlorate and nitrate in spent ion-exchange regenerant brine containing at least 30 g/L NaCl under anaerobic/anoxic conditions was used to demonstrate the process. A stabilized brine solution is also disclosed in which a culture capable of degrading a given pollutant can be proliferate.
Type:
Grant
Filed:
November 19, 2004
Date of Patent:
July 8, 2014
Assignee:
The University of Houston System
Inventors:
Deborah J. Roberts, Dennis A. Clifford, Xiaohua Lin, Thomas Gillogly, Lee Aldridge, Stewart Lehman